By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



5 Centerpointe Drive
Suite 400
Lake Oswego  Oregon  97035  U.S.A.
Phone: 971-204-0382 Fax: n/a



Company News
CytoDyn Hires New Senior Vice President Of Manufacturing For PRO 140 11/24/2015 8:18:02 AM
CytoDyn Announces Investment Community Conference Call 11/18/2015 7:30:54 AM
CytoDyn Injects First Patient In Its Current Phase III Study 10/22/2015 7:42:22 AM
CytoDyn Files An IND And Full Protocol For Phase II Study In GvHD 10/20/2015 7:25:07 AM
CytoDyn Release: HIV Patients Successfully Reach One Year Of Virologic Suppression In PRO 140 Monotherapy Study 9/21/2015 8:10:23 AM
CytoDyn Release: First Self-Injectable HIV Antibody: 98% Success Rate In Phase 2b Clinical Trial, Could Be Commercial 8/18/2015 10:57:08 AM
CytoDyn Initiates First Clinical Site For Phase III Trial Of PRO 140 8/6/2015 7:32:04 AM
CytoDyn Completes Qualification Of PRO 140 Material For Phase III 7/29/2015 7:52:23 AM
CytoDyn Release: Evidence Of HIV Suppression With PRO 140 Monotherapy Reaching Nearly 11 Months 7/15/2015 7:15:51 AM
CytoDyn To Expand Clinical Applications For PRO 140 Beyond Therapy For HIV 6/24/2015 11:22:31 AM